Literature DB >> 1390195

Neutrophil-oxidized low density lipoprotein: generation in and clearance from the plasma.

P Görög1.   

Abstract

The prevailing concept of an extremely rapid disappearance of 'modified' low density lipoprotein (LDL) from the circulation was reinvestigated. Rabbit LDL was 'modified' by homologous activated (phagocytosing) polymorphonuclear leucocytes (PMLN), radiolabelled with a non-degradable ligand (125I-TC-LDL) and injected into rabbits. The plasma half-lives of 'modified' and native LDL were T1/2 = 2.5 and 5.75 h, respectively. Furthermore, the possibility of LDL oxidation in plasma by stimulated PMNL was investigated. Hirudin-anticoagulated human plasma was incubated with unstimulated or stimulated autologous PMNL. Chemiluminometry (reactants with microperoxidase) of the lipid extract of plasma after incubation showed lipid peroxidation to be induced by phagocytosing, but not by quiescent, leucocytes. These findings show that in plasma, stimulated leucocytes can 'modify' LDL and the circulatory half-life of the latter enables its contribution to atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390195      PMCID: PMC2002350     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  26 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Sera containing elevated nonesterified fatty acids from patients with angiographically documented coronary atherosclerosis cause marked lipid accumulation in cultured human arterial smooth muscle-derived cells.

Authors:  C W Laughton; D L Ruddle; C J Bedord; E L Alderman
Journal:  Atherosclerosis       Date:  1988-04       Impact factor: 5.162

3.  Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

Authors:  J A Berliner; M C Territo; A Sevanian; S Ramin; J A Kim; B Bamshad; M Esterson; A M Fogelman
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity.

Authors:  M Aviram; G Dankner; J G Brook
Journal:  Arteriosclerosis       Date:  1990 Jul-Aug

5.  A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo.

Authors:  R C Pittman; T E Carew; C K Glass; S R Green; C A Taylor; A D Attie
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

6.  Activation of human blood monocytes by oxidized polyunsaturated fatty acids: a possible mechanism for the generation of lipid peroxides in the circulation.

Authors:  P Görög
Journal:  Int J Exp Pathol       Date:  1991-04       Impact factor: 1.925

7.  Serum lipids, lipid peroxides and the care of children with high risk atherosclerotic family history.

Authors:  T Szamosi; I Gara; I Venekei; A Jávor; R Ceskel; J Knoll
Journal:  Atherosclerosis       Date:  1987-11       Impact factor: 5.162

8.  Enhanced cholesterol delivery to cells in culture by low density lipoproteins from hypercholesterolemic monkeys.

Authors:  R W St Clair; P Greenspan; M Leight
Journal:  Arteriosclerosis       Date:  1983 Jan-Feb

9.  Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages.

Authors:  H F Zhang; H J Basra; U P Steinbrecher
Journal:  J Lipid Res       Date:  1990-08       Impact factor: 5.922

10.  Antioxidant defenses and lipid peroxidation in human blood plasma.

Authors:  B Frei; R Stocker; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

View more
  4 in total

1.  Blood polymorphonuclear leukocyte activation in atherosclerosis: effects of aspirin.

Authors:  G Egger; A Burda; A Obernosterer; H Mitterhammer; G Kager; G Jürgens; H P Hofer; J S Fabjan; E Pilger
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  Blood polymorphonuclear leukocyte migratory activities during rheumatoid arthritis.

Authors:  G Egger; F Aglas; F Rainer
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

3.  White Blood Cells, Neutrophils, and Reactive Oxygen Metabolites among Asymptomatic Subjects.

Authors:  Kazuhiko Kotani; Naoki Sakane
Journal:  Int J Prev Med       Date:  2012-06

4.  Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing.

Authors:  Pamela R Hall; Bradley O Elmore; Cynthia H Spang; Susan M Alexander; Brett C Manifold-Wheeler; Moriah J Castleman; Seth M Daly; M Michal Peterson; Erin K Sully; Jon K Femling; Michael Otto; Alexander R Horswill; Graham S Timmins; Hattie D Gresham
Journal:  PLoS Pathog       Date:  2013-02-14       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.